Literature DB >> 22887932

Carotid artery access for transcatheter aortic valve replacement.

Robert A Guyton1, Peter C Block, Vinod H Thourani, Stamatios Lerakis, Vasilis Babaliaros.   

Abstract

We report three patients who had successful transcatheter aortic valve replacement (TAVR) via carotid artery access. None were candidates for thoracotomy (including minimal access incisions) and had no other vascular access sites that would accommodate the transcatheter valve sheath. Antegrade carotid perfusion and retrograde insertion of the delivery sheath maintained cerebral blood flow without sequelae. Carotid access for TAVR is an option for unusual patients without other access.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  aortic stenosis; carotid; transcatheter aortic valve replacement (TAVR)

Mesh:

Year:  2013        PMID: 22887932     DOI: 10.1002/ccd.24596

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

Review 1.  Vascular approaches for transcatheter aortic valve implantation.

Authors:  Isaac Pascual; Amelia Carro; Pablo Avanzas; Daniel Hernández-Vaquero; Rocío Díaz; Jose Rozado; Rebeca Lorca; María Martín; Jacobo Silva; César Morís
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Particulates from hydrophilic-coated guiding sheaths embolise to the brain.

Authors:  James R L Stanley; Abraham R Tzafriri; Kathryn Regan; Alan LaRochelle; Gee Wong; Brett G Zani; Peter M Markham; Lynn Bailey; Anna Spognardi; Gregory A Kopia; Elazer R Edelman
Journal:  EuroIntervention       Date:  2016-03       Impact factor: 6.534

Review 3.  Non-transfemoral access sites for transcatheter aortic valve replacement.

Authors:  Mariah Madigan; Rony Atoui
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 4.  Transcatheter Aortic Valve Implantation.

Authors:  S Chris Malaisrie; Adam Iddriss; James D Flaherty; Andrei Churyla
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.